The Subcutaneous Immunoglobulin (SCIG) Market focuses on the development, production, and distribution of immunoglobulin replacement therapies administered via subcutaneous injection for the treatment of primary immunodeficiency disorders (PIDDs), autoimmune diseases, and neurological conditions. SCIG therapy delivers purified immunoglobulin G (IgG) antibodies directly into the subcutaneous...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek